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Abstract
Background:  Cell proliferation and apoptosis are both involved in arterial wall remodeling.
Increase in blood flow induces arterial enlargement. The molecular basis of flow-induced
remodeling in large elastic arteries is largely unknown.
Methods: An aortocaval fistula (ACF) model in rats was used to induce enlargement in the
abdominal aorta. Aortic gene expression of transforming growth factors beta (TGF-β ) and
apoptosis-related factors was assessed at 1 and 3 days and 1, 2, 4, and 8 weeks. Expression levels
were determined using a ribonuclease protection assay and western blotting. Cell proliferation and
apoptosis were analyzed using BrdU incorporation and TUNEL techniques.
Results: Blood flow increased 5-fold immediately after ACF (P<0.05). Lumen diameter of the aorta
was 30% and 75% larger at 2 and 8 weeks respectively than those of controls (P<0.05). mRNA
levels of TGF-β 1 and TGF-β 3 increased after ACF, peaked at 3 days (P<0.05) and returned to
normal level at 1 week and thereafter. Western blotting showed enhanced expression of TGF-β 1
at 3 days and TGF-β 3 at 1 and 3 days and 1 week (P<0.05). mRNA levels of Bcl-xS initially decreased
at 1 day, 3 days and 1 week, followed a return to baseline level at 2 weeks. Cell proliferation was
observed at all time points after ACF (P<0.001 vs. controls) with proliferation in endothelial cells
more significant than smooth muscle cells. Apoptosis was not significant.
Conclusions: Gene expression of TGF-β 1 and β 3 precedes arterial enlargement. Expression of
apoptosis related factors is little regulated in the early stage of the flow-induced arterial
remodeling.
Background
The arterial wall remodels in response to hemodynamic
forces imposed on it by blood pressure and blood flow.
The processes of arterial remodeling involve regulation of
vascular cell dynamics and control of matrix synthesis and
degradation [1]. Endothelial cell (EC) proliferation is ob-
served in flow-induced arterial dilation [2] and in vessel
luminal expansion in mesenteric arterial collaterals in the
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rat [3]. Smooth muscle cells (SMC) have also been shown
to proliferate in the vessel dilatation remodeling [3]. In
the meantime, extracellular matrix (ECM) is involved in a
variety of remodeling processes [4–9] including flow-in-
duced arterial dilation [10]. These observations indicate
that cell proliferation and ECM accumulation are critically
involved in vessel remodeling. Furthermore, degenerative
or destructive changes in both cellular and extracellular
components of the vessel wall are also evidenced in many
situations involving vessel dilatation changes. The inter-
nal elastic lamella of arteries is shown to form gaps prior
t o  v e s s e l  d i l a t a t i o n  i n  a n  e x p e r i m e n t a l  a r t e r i o v e n o u s
model in rabbit carotid artery [2]. Collagenase and matrix
metalloproteinases (MMPs) have been observed to be up-
regulated during vessel dilation either in flow-induced
model [10] or in a post-stenotic dilatation [11].
Several growth factors, in particular TGF-β , have been
shown to be involved in vessel wall remodeling with re-
spect to both cellular proliferation and ECM accumula-
tion [12–15]. Cell apoptosis has been shown to play a role
in various remodeling processes [1], including hyperten-
sion-induced remodeling [6] and subnormal shear stress
induced endothelial cell apoptosis [16]. Interestingly,
TGF-β  super family has been related to apoptosis in vascu-
lar cells [17]. However, whether flow-induced arterial dil-
atation may also associated with apoptosis and how it
might be coordinated with cell proliferation in a large
elastic artery remain unclear. The present study was aimed
to assess gene expression of both TGF-β  and apoptosis re-
lated molecules in early response of the artery to an in-
crease in blood flow in rat abdominal aorta.
Methods
Animal model of aortocaval fistula
The aortocaval fistula (ACF) [18,19] was created between
the infrarenal abdominal aorta and the adjacent vena cava
in male Sprague-Dawley rats weighing 250–300 g. All pro-
cedures were carried out following the guidelines set forth
in the Resource Manual for the Care and Use of Animals in
Research and Teaching at Stanford University. Surgical proce-
dures were carried out with sterile technique under a sur-
gical microscope. Rats were under general anesthesia with
an intraperitoneal injection of sodium pentobarbital (50
mg/kg). Through a midline abdominal incision the infra-
renal abdominal aorta and the inferior vena cava were vis-
ualized. The aortic blood flow was stopped by a microvas-
cular clamp placed 5 mm above the iliac bifurcation. A
side-to-side ACF was constructed by a needle puncture
method using a 19-guage needle. The outer wall of the
aorta distal to the clamp was pierced with the needle,
which was then advanced into the vena cava. The needle
was subsequently retrieved and the arteriotomy was
closed with 8–0 silk suture. The clamp was then removed
and the vena cava was evaluated for bright red color, an
indication of a successful ACF. The abdominal wall was
closed with silk suture. The skin was then closed with
microsurgical clips. Sham operated rats underwent the
same surgical procedure except that only the aortic wall
was pierced and subsequently closed without ACF con-
struction.
Time course of study
Animals were sacrificed 1 and 3 days, 1, 2, 4, and 8 weeks
after surgery (n = 3 for each time point). Equal number of
sham operated and age matched animals served as con-
trols. Two sets of animals were used. One was for extrac-
tion of total tissue RNA and protein and one for perfusion
fixation for histology.
Blood flow measurement and wall shear stress calculations
Blood flow rate (mL/min) in the infra-renal aorta was
measured by micro Doppler velocimetry before and im-
mediately after ACF construction and again at the end of
the experiment. Wall shear stress (WSS) was calculated us-
ing the Hagen-Poiseuille formula τ W = 0.1 ×  4 µQ/π r3,
where τ W is WSS in newtons per square meter (Pa), µ is
the blood viscosity (0.03 poise), Q is blood flow rate (mL/
s), and r is arterial lumen radius (centimeter) [2].
Sampling and perfusion fixation
The infra-renal aorta of 5 mm long, starting 2 mm proxi-
mal to the fistula, was harvested and immediately frozen
in liquid nitrogen for extraction of total RNA and protein
by using Trizol Reagent (Life Technologies, Inc. Rockville,
MD). For histological study the animals were perfusion
fixed through a catheter in the left ventricle of the heart
with 4% paraformaldehyde at room temperature and at a
pressure of 100 mmHg for 30 minutes. This was per-
formed in an attempt to preserve the physiological archi-
tecture of the vessel wall and to prevent the vessel from
collapsing as described previously [6]. The aorta was then
taken and further fixed in 4% paraformaldehyde for two
more hours. The standard site for sectioning was at 4 mm
proximal to the fistula orifice, which is equivalent to the
middle portion of the samples for total RNA extraction.
Paraffin embedded and frozen sections were prepared as
needed.
Ribonuclease protection assay
Relative mRNA levels were assessed using ribonuclease
protection assay (RPA) to determine gene expression of
growth factors and apoptosis related molecules. Non-radi-
oactive RNA probes were transcribed from multi-probe
template set for rat cytokines (rCK-3) and a set for rat ap-
optosis factors (rAPO-1), (Pharmingen, San Diego, CA)
[6]. An in vitro RNA transcription kit (Promega, Madison,
WS) was applied with the addition of biotin-16-UTP for
labeling the probes (Roche, Indianapolis, IN). The sensi-
tivity and specificity of the probes were carefully tested be-BMC Cardiovascular Disorders 2002, 2 http://www.biomedcentral.com/1471-2261/2/11
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fore starting the experiment. Five micrograms of total RNA
from each animal were hybridized with the probes and an
RPA-III kit (Ambion, Austin, TX) was used for RPA follow-
ing the manufacturer's protocols. The protected fragments
of the probes were resolved in 5% denaturing polyacryla-
mide gel followed by blotting to a positively-charged ny-
lon membrane. The resolved probes were detected using
BrightStar kit (Ambion) and exposed to films. The result-
ed films were scanned, and densitometry was performed
with NIH Image program version 1.62 (National Insti-
tutes of Health, Bethesda, MD). The relative values of pro-
tected probe fragments were expressed as a ratio of their
densitometry values over those of GAPDH (glyceralde-
hyde- 3-phosphate dehydrogenase) in the same lane. The
mean and SD were calculated for each time point.
Western blot analysis and immunohistochemistry
Western blotting analysis was performed for analyses of
TGF-β 1 and β 3 as well as Bcl-xS. All procedures were pub-
lished previously [6,20]. In brief, protein samples of 25 µg
in 2 ×  sodium dodecylsulfate loading buffer were fraction-
ated by 10% sodium dodecylsulfate-polyacrylamide gel
electrophoresis at 100 V. The proteins were transferred
onto 0.45-µm pore nitrocellulose membrane (Schleicher
& Schuell, Keene, NH) at 40 V for 45 to 60 minutes. The
membranes were blocked with 5% nonfat milk and incu-
bated at room temperature for 1 hour with anti-TGF-β 1
polyclonal antibody at a 1:200 dilution, anti-TGF-β 3 pol-
yclonal antibody at a 1:1000 dilution, and anti Bcl-xS pol-
yclonal antibody at 1:500 dilution. After extensive washes
with phosphate buffered saline, the blots were incubated
with appropriate secondary antibodies (1:1000) conjugat-
ed with horseradish peroxidase for 1 hour at room tem-
perature. The blots were washed three times in phosphate-
buffered saline, and the protein complexes were detected
with enhanced chemiluminescence detection reagents ac-
cording to the manufacturer's protocol (Amersham Phar-
macia Biotech, Inc, Piscataway, NJ). The presented data
are the results from three animals in each of the time
points. Protein samples from each animal were fractionat-
ed on more than one gel, in duplicate or triplicate.
Immunohistochemistry was performed on paraffin sec-
tions, 4 micron in thickness, following previous protocols
[5]. The same antibodies used for western blotting were
used for detection of TGF-β 1 and TGF-β 3 with optimized
dilutions. Sections were de-paraffinized and rehydrated in
PBS, followed by incubation in 3% H2O2 in PBS for 10
minutes. After washes in PBS for 5 minutes, the sections
were incubated in 1:100 diluted horse serum for 30 min-
utes. Sections were incubated with primary antibody at
1:50 dilution in PBS for 1 hour at room temperature. After
3 washes in PBS, the sections were incubated with the cor-
responding biotinylated secondary antibody (Vector Lab-
oratories, Inc, CA) at 1:200 dilutions for 1 hour at room
temperature followed by ABC-DAB method (Vector Labo-
ratories, Inc) according to the manufacturer's protocol.
The detection was brown precipitates as a result of the re-
action of DAB with horse radish peroxidase. The sections
were counterstained with hematoxylin and coverslipped.
Cell proliferation evaluation and apoptosis detection
Incorporation and detection technique [6] of 5-bromo-2'-
deoxy-uridine (BrdU) was used to assess DNA synthesis
during cell proliferation. Three injections of BrdU (Sigma,
St Louis, Mo), 50 mg/kg body weight, were administered
intraperitoneally to the animals 20, 6, and 1 hours before
they were humanely killed. Immunodetection of BrdU in-
corporation was performed on frozen sections with a de-
tection kit (Roche). The cell type of BrdU-incorporated
cells was assessed histologically. In addition, an antibody
against α -actin (Enzo Diagnostics, Inc, Farmingdale, NY)
was used to confirm SMCs in the media. The number of
BrdU-labeled nuclei was counted from each whole cross
section. The mean and SD were obtained from three ani-
mals for each time interval, and the cell proliferation rate
was expressed as a number of labeled nuclei per section.
Terminal deoxynucleotidyl transferase-mediated dUTP
nick end-labeling (TUNEL) method was used to demon-
strate apoptosis in SMCs and endothelial cells [6]. The
TUNEL was performed on frozen sections. An in situ cell
death detection kit (Roche) was used for TUNEL with
modifications. Nuclei of apoptotic cells were thus labeled
with fluorescein, and the sections were counterstained
with propidium iodide and observed under laser-scan-
ning confocal microscope (Bio-Rad MRC 1024, Hercules,
CA). Negative controls were included by omitting the la-
beling buffer. Positive controls were obtained by digestion
of the sections with deoxyribonuclease I for 10 minutes at
room temperature before the detection procedure. La-
beled nuclei were counted per section. The mean and SD
of each time point were obtained from three animals for
statistical analysis.
Histology and morphometry
Cross sections from the perfusion fixed specimens were
stained with H.E. and Mason's trichrome staining. The
sections were digitized by tracing the contours of the lu-
men, the internal elastic lamella, and the external elastic
lamella. The lumen diameter was calculated from the cir-
cumference of the lumen. The external diameter was cal-
culated from the circumference of the external elastic
lamella. The average wall thickness was the difference of
the two diameters divided by 2. Mean and SD were calcu-
lated from 3 sections of each time point.
Statistical analysis
Data were presented as mean ± SD. Single factor analysis
of variance (ANOVA) and Bonferroni's test were used for
multiple-comparisons. StatView software version 5.0 (SASBMC Cardiovascular Disorders 2002, 2 http://www.biomedcentral.com/1471-2261/2/11
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Institute Inc, San Francisco, CA) was used for the statisti-
cal analysis. The difference was considered significant if P
< 0.05.
Results
Blood flow, wall shear stress, lumen diameter, and wall 
thickness
The ACF produced an increase in blood flow and therefore
WSS in the infrarenal aorta by more than 5 folds after sur-
gery (Table 1). Morphometry revealed an increase in lu-
men diameters. The lumen diameter started to increase at
1 week after ACF although this change did not reach sta-
tistical significance. At 2 weeks and thereafter, the lumen
diameters were significantly larger than those of controls,
which were accompanied with decreased wall thickness
(Figure 1 and table 1).
Expression of cell growth related cytokines
RPA using the multiple probes of rCK-3 revealed an upreg-
ulation of both TGF-β 1 and TGF-β 3 gene expression. The
relative mRNA levels of them increased with a peak at 3
days. The levels declined after 3 days and returned to con-
trol levels (Figure 2, left panels). Western blot analysis
showed an increase in the protein levels with a similar
trend to mRNA levels for both TGF-β 1 and β 3 (Figure 2,
right panels). Moreover, TGF-β 3 protein levels remained
high at 1 week. These changes preceded the aortic enlarge-
ment, which happened at 2 weeks. Immunohistochemis-
try revealed detection of both TGF-β 1 and β 3 after flow
increased. The increased expression peaked at 1 and 3
days compared to controls. The expression of these
growth factors was closely associated with immunohisto-
chemical staining (Figure 3). The SMC in the inner and
outer zones of the media seemed to be more involved in
the expression of these growth factors.
Expression of apoptosis-related molecules
RPA with the multiple-probe of rAPO-1 showed that rela-
tive mRNA levels of Bcl-x short isoform (Bcl-xS), known as
pro-apoptotic factors, initially decreased at 1 day, 3 days
and 1 week followed by returning to base line level after
2W (Figure 4). There was an increase in caspase-3 and Bax
mRNA levels at 4W. Other factors did not show significant
changes. Western blotting analysis showed a similar trend
of mRNA level for Bcl-xS (Figure 4), but statistical out-
come did not reach significance. Immunohistochemistry
did not show any apparent detection of these molecules.
Cell proliferation
Cell proliferation was remarkable for both EC and SMC
with EC more significant than SMC (Figure 5). BrdU in-
corporated nuclei were observed in the media, along the
endothelial line and in the adventitia. The incorporation
rate for endothelial cells increased at 1 week and thereafter
(P < 0.05 vs. controls) and the incorporation rate of SMC
increased at 4 weeks (P < 0.05 vs. controls) (Table 1).
Cell apoptosis
Apoptosis of vascular cells was assessed by TUNEL meth-
od in all animals. There was no remarkable difference in
apoptosis rate after ACF creation (data not shown).
Discussion
Vascular wall remodeling in response to hemodynamic al-
terations has been known closely related to lesion devel-
opment in the arterial wall [21–23]. Arterial wall shear
stress is proven to be a critical factor in regulation of vessel
diameter. Increase in blood flow, or shear stress, induces
enlargement of the artery [2,24–26]; and decrease in shear
stress results in reduction of lumen diameter of the artery
[26–28].

















Ctrl1 8.0 ± 1.0 5.2 ± 0.7 0.918 ± 0.104 0.075 ± 0.004 0.6 ± 0.8 0.2 ± 0.3
1D 42.5 ± 5.3* 36.5 ± 4.6* 0.838 ± 0.088 0.068 ± 0.004 4.2 ± 4.3 2.8 ± 2.9
3D 52.3 ± 28.6* 41.9 ± 22.9* 0.866 ± 0.041 0.063 ± 0.003 2.9 ± 2.2 1.5 ± 1.5
1W 40.3 ± 17.7* 23.2 ± 10.2* 0.960 ± 0.030 0.057 ± 0.004 3.6 ± 1.6* 1.4 ± 1.2
2W 43.5 ± 13.0* 13.5 ± 4.0* 1.188 ± 0.078* 0.044 ± 0.002* 4.1 ± 3.2* 1.4 ± 0.8
4W 46.2 ± 6.8* 10.2 ± 1.5* 1.322 ± 0.0751* 0.036 ± 0.003* 4.0 ± 0.9* 2.5 ± 2.3*
8W 46.3 ± 9.3* 5.8 ± 1.2 1.604 ± 0.162* 0.030 ± 0.003* 7.5 ± 0.7* 1.5 ± 0.7
1 Values of all controls were pooled. * P < 0.05 as compared to controlsBMC Cardiovascular Disorders 2002, 2 http://www.biomedcentral.com/1471-2261/2/11
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The present study once again demonstrated that increased
blood flow rate induced arterial enlargement in an aorto-
caval fistula model in rats. More significantly, this model
subjects the abdominal aortic aorta to a condition of an
acute increase in blood flow. So far, most of vessel remod-
eling studies are based on peripheral arteries, such as ca-
rotid and iliac arteries. There are very few models using
larger and elastic arteries like aorta for study of flow-in-
duced response [19]. The current model provides a direct
access to the investigation of abdominal aorta with blood
flow-induced hemodynamic alteration.
The study showed that the adaptive enlargement was asso-
ciated with increased gene expression of TGF-β 1 and β 3,
known as tissue remodeling mediators [12,17,29]. Gene
expression of TGF-β 1 and β 3 was upregulated at 1 and 3
days and 1 week upon increase in blood flow, while the
flow-induced aortic enlargement occurred 2 weeks after
ACF creation. Furthermore, the expression of these growth
factors mainly associated with endothelial cells and
smooth muscle cells in the inner media. These results sug-
gest that the function of TGF-β  superfamily may be a pre-
requisite for the arterial dilatation and that endothelial
cells and the smooth muscle cells may be responsible for
the forth-going vessel enlargement.
TGF-β  expression is closely associated with an increase in
wall shear stress [30,31] and with different forms of fluid
shear stress [32], and its function is modulated by variety
of factors [14]. For example, TGF-β 1 is secreted in an inac-
tive precursor and requires furin-mediated maturation
[33]. TGF-β 1 in turn induces expression of furin. It has
been demonstrated that both furin and TGF-β  gene ex-
pression was upregulated by fluid shear stress in vascular
endothelial cells. Thus, the positive feedback may en-
hance the effect of TGF-β 1 on endothelial cells and vascu-
lar smooth muscle cells as demonstrated by Negishi et al.
[15]. The present study demonstrated that fluid shear
stress induced regulation of TGF-β  expression in the larger
elastic artery. Furthermore, TGF-β  upregulation was asso-
ciated with cell proliferation, which was significant at al-
most all time points, with EC more remarkable than SMC.
TGF-β  superfamily of growth factors is powerful and sub-
tle regulation of its expression may exert a remarkable ac-
tion. TGF-β  is a potent regulator of the cell cycle in many
cell types including vascular smooth muscle and endothe-
lial cells, and as a result this growth factor has been postu-
lated to play an important, though largely undefined, role
in vascular proliferative processes [14]. So far, little is
known about the modulation role of TGF-β 3 in vessel re-
modeling. It is known that TGF-β 3 plays a role in cardiac
morphogenesis, mammary gland development and
wound healing and that TGF-β 3 is involved in fine-tuned
interactions between epithelial and mesenchymal cells
and their products [34]. The exact role of TGF-β 3 in vascu-
lar remodeling response remains unclear. It is conceivable
Figure 1
Dimensional changes after ACV Lumen diameter and wall thickness were changed after creation of ACV as compared to
non-operated control and sham-operated control, which were subjected to the operation but no ACF was created. See table 1
for detailed morphometry results.BMC Cardiovascular Disorders 2002, 2 http://www.biomedcentral.com/1471-2261/2/11
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that after an acute regulation of cell proliferation and
ECM degradation, TGF-β 3 may exert a fine tune up be-
tween cells and ECM for a reconstruction of the remod-
eled wall.
The mechanical and biochemical mechanisms of flow or
shear-regulated arterial dilatation and the vessel remode-
ling have been widely studied [35]. Vessel wall shear stress
exerted by blood flow is a regulating mechanical force on
endothelial cells that has important physiological and
pathological cardiovascular consequences. The endotheli-
al monolayer in vivo acts as a signal transduction interface
for mechanical forces, in particular, shear stress. Mecha-
nisms related to spatial relationships at the cell surfaces
and throughout the cells in the wall that influence flow-
mediated endothelial mechanotransduction involve
many cytokines including TGF-β  superfamily. Further-
more, flow-mediated ion channel activation and cytoskel-
etal dynamics are related to topographic characteristics of
the luminal and abluminal surfaces of living endothelial
cells [35].
Arterial dilatation is thought to be endothelial dependent
[26,36]. Endothelial proliferation during the flow-in-
duced arterial enlargement has been shown to be a char-
acteristic event [2]. The vessel enlargement results in an
increase in lumen surface area while endothelial cell pro-
liferation assures a continuous cell lining throughout.
Our observation indicated that apoptosis was not remark-
able in the early stage of flow-induced dilatation; al-
though apoptosis has been implicated to play a role in
vessel remodeling [1]. There was little change in TUNNEL
analysis after ACF creation. However, some apoptosis-re-
lated factors were regulated. For example, the mRNA lev-
els of Bcl-xS were initially decreased at 1 day, 3 days and 1
week followed by returning to base line level after 2
weeks. There was an increase in caspase-3 and Bax mRNA
levels at 4 weeks. Follow up western blotting analysis was
Figure 2
RPA and western blot for TGF-β  Left panels, top: A representative film resulted from an RPA procedure showing the
major bands, which correspond to TGF-β 1 at the 256 base level and TGF-β 3 at 226 base level as well as GAPDG at 97 base
level according to the manufacturer's design. The far left lane shows the multiple probes without RNase digestion. The far right
lane shows molecular markers. Bottom: Relative mRNA levels of TGF-β 1 and β 3. Data are expressed as density ratio of TGF-
beta over GAPDH from three separate experiments. Both TGF-β 1 and TGF-β 3 were highly expressed with a peak at 3 day for
each. The mRNA levels were declined after 3 days and returned to control levels. * P < 0.05 compared to controls (Ctrl). Right
panels, top: Representative bands of Western blot analysis for TGF-β 1 and TGF-β 3. Bottom: Densitometry values show similar
trend to mRNA levels for both TGF-β 1 and β 3. * P < 0.05 compared to controls (Ctrl). Data are means from three separate
experiments. D, Day; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; W, week.BMC Cardiovascular Disorders 2002, 2 http://www.biomedcentral.com/1471-2261/2/11
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unable to determine the expression trends, suggesting that
cell apoptosis regulation in vivo may be too subtle to be
detected.
Apoptosis related molecules, such as Bcl-xS, Bax, and case-
pase-3, are known to be proapoptotic factors and involved
in variety of vessel remodeling processes [37–39]. The in-
itial arrest in Bcl-xS gene expression may momentarily de-
press apoptosis. It is conceivable that during the early
stage of the remodeling, cell proliferation is the dominant
response and apoptosis may be somewhat repressed to fa-
vor cell survival. This is contested by the little changes in
TUNEL detection.
Conclusions
In summary, the experiments demonstrate that gene ex-
pression of TGF-β 1 and β 3 precedes the flow induced ar-
terial enlargement and is associated with cell
proliferation. Expression of apoptosis-related molecules,
such as Bcl-xS, Bax, and caspase-3, seems to be little regu-
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Figure 3
Immunohistochemical staining for TGF-β  Immunohistochemical staining of TGF-β 1 (A to D) and β 3 (E to H). The brown
color indicates the detection. There was a slight detection of both TGF-β 1 and β 3 in controls (A, E). The peak staining was at
3 days after ACF for TGF-β 1 (B, C) and at 3 days and 1 week for β 3 (F, G). SMC showed stronger staining. Furthermore, SMC
in the inner and outer zones of the media seemed to be more involved. Panels D and H are negative controls (NC), in which
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Figure 4
RPA results of apoptosis-related factors A representative of RPA results is shown in panel A with multiple probes of
apoptosis related cytokines. The RPA showed that relative mRNA levels of Bcl-xS were initially decreased at 1 day, 3 days and
1 week followed by returning to base line level after 2W (B). There was an increase in caspase-3 and Bax mRNA levels at 4w.
Data are expressed as density ratio of TGF-beta over GAPDH from three separate experiments. Western blotting analysis
showed a similar trend (C) to the mRNA levels for Bcl-xS but statistical analysis did not reach significance. * P < 0.001 com-
pared to controls.BMC Cardiovascular Disorders 2002, 2 http://www.biomedcentral.com/1471-2261/2/11
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